Libido in the menopausal woman

Megan Ogilvie discusses women's libido including menopausal hormone treatment, and testosterone supplementation.

Topics:

• 00:00 Intro
• 00:55 Changes to libido over lifespan.
• 07:00 Changes to Testosterone over lifespan
• 09:00 Consensus statement for testosterone supplementation
• 10:29 Indications for testosterone supplementation
• 11:45 What is a loss of libido?
• 13:02 How to ask these personal questions.
• 14:40 Investigations Do we measure testosterone?
• 15:56 Do we think about lipids?
• 16:19 Stepped approach to management
• 18:20 How is AndroFem used?
• 22:33 Monitoring
• 23:25 Is it subsidised?
• 24:01 Why is prescribing low?
• 25:47 Any side effects?
• 26:36 Is there ever a place for compounding testosterone?
• 28:26 Should we be screening these women for breast cancer?
• 29:08 More information
• 29:46 Take home messages

Resources

• Testosterone and Women Australasian Menopause Society
• Webinar: What’s new - The use of testosterone in women  AMS (2021)
• Female sexual dysfunction: the place for testosterone Goodfellow MedCase (2020)
• Effects of testosterone therapy for women: a systematic review and meta-analysis protocol Syst Rev. (2019)
• The Safety of Testosterone Therapy in Women JOGC  (2012)
•  Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The Journal of Clinical Endocrinology & Metabolism (2019)
• Menopause resources Health Navigator NZ

Presenter

Megan Ogilvie
Endocrinologist

Megan graduated from University of Auckland and completed specialist endocrine training in Auckland. She undertook postgraduate training at St Bartholomew’s Hospital and subsequently at Middlesex Hospital in London. Megan joined Fertility Associates in 2004 working in the areas of both general and reproductive endocrinology with particular interests in polycystic ovarian syndrome (PCOS), amenorrhoea, menopause and gonadal dysgenesis.